$MEDE
Medies

2024 Q1 Form 10-K Financial Statement

#000168316824004100 Filed on June 11, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2024 2023
Revenue $0.00 $0.00 $1.840K
YoY Change -100.0%
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00 $1.840K
YoY Change -100.0%
Gross Profit Margin 100.0%
Selling, General & Admin $14.90K $39.45K $63.16K
YoY Change -37.54% 9768.75%
% of Gross Profit 3432.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $20.33K $7.788K $18.77K
YoY Change -58.51% 4165.91%
% of Gross Profit 1020.11%
Operating Expenses $14.90K $39.45K $63.16K
YoY Change -37.54% 9768.75%
Operating Profit -$14.90K -$39.45K -$61.32K
YoY Change -35.67% 9481.25%
Interest Expense $520.00 $0.00 $700.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net -$15.12K $694.00
YoY Change -2279.11%
Pretax Income -$29.50K -$54.57K -$60.63K
YoY Change -10.0% 9373.44%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$29.50K -$54.57K -$60.63K
YoY Change -10.0% 9373.44%
Net Earnings / Revenue -3295.11%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 6.667M shares 6.667M shares 4.941M shares
Diluted Shares Outstanding 6.667M shares 4.941M shares

Balance Sheet

Concept 2024 Q1 2024 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $400.00 $400.00 $1.860K
YoY Change -78.49% 365.0%
Cash & Equivalents $402.00 $400.00 $1.860K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $402.00 $400.00 $1.860K
YoY Change -78.41% -78.49% 365.0%
LONG-TERM ASSETS
Property, Plant & Equipment $22.94K $22.94K $30.73K
YoY Change -25.34% -25.35% -20.2%
Goodwill
YoY Change
Intangibles $0.00
YoY Change -100.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $22.94K $22.94K $58.91K
YoY Change -61.06% -61.06% -9.61%
TOTAL ASSETS
Total Short-Term Assets $402.00 $400.00 $1.860K
Total Long-Term Assets $22.94K $22.94K $58.91K
Total Assets $23.34K $23.34K $60.77K
YoY Change -61.59% -61.59% -7.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $10.17K $10.17K $1.000K
YoY Change 915.88% 917.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $63.44K $63.44K $55.47K
YoY Change 14.37% 37.61%
Total Short-Term Liabilities $73.61K $73.61K $56.47K
YoY Change 30.36% 30.35% 40.09%
LONG-TERM LIABILITIES
Long-Term Debt $12.50K $12.50K $12.50K
YoY Change 0.0%
Other Long-Term Liabilities $25.50K $25.50K $25.50K
YoY Change 0.0% 0.0%
Total Long-Term Liabilities $38.00K $38.00K $38.00K
YoY Change 0.0% 0.0% 49.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $73.61K $73.61K $56.47K
Total Long-Term Liabilities $38.00K $38.00K $38.00K
Total Liabilities $111.6K $111.6K $94.47K
YoY Change 18.14% 18.14% 43.55%
SHAREHOLDERS EQUITY
Retained Earnings -$115.8K
YoY Change 89.07%
Common Stock $667.00
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$88.27K -$88.27K -$33.70K
YoY Change
Total Liabilities & Shareholders Equity $23.34K $23.34K $60.77K
YoY Change -61.59% -61.59% -7.32%

Cashflow Statement

Concept 2024 Q1 2024 2023
OPERATING ACTIVITIES
Net Income -$29.50K -$54.57K -$60.63K
YoY Change -10.0% 9373.44%
Depreciation, Depletion And Amortization $20.33K $7.788K $18.77K
YoY Change -58.51% 4165.91%
Cash From Operating Activities -$3.450K -$9.432K -$40.86K
YoY Change -76.92% 20330.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 $12.50K
YoY Change -100.0% -80.95%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00 -$12.50K
YoY Change -100.0% -80.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.450K $7.973K 54.82K
YoY Change -85.46% -17.2%
NET CHANGE
Cash From Operating Activities -3.450K -$9.432K -40.86K
Cash From Investing Activities 0.000 $0.00 -12.50K
Cash From Financing Activities 3.450K $7.973K 54.82K
Net Change In Cash 0.0000000000009095 -$1.459K 1.460K
YoY Change -199.93% 265.0%
FREE CASH FLOW
Cash From Operating Activities -$3.450K -$9.432K -$40.86K
Capital Expenditures $0.00 $0.00 $12.50K
Free Cash Flow -$3.450K -$9.432K -$53.36K
YoY Change -82.32% -18.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0001918694
CY2024 dei Document Type
DocumentType
10-K
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-02-29
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-29
CY2024 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 210
CY2024 dei Entity Address City Or Town
EntityAddressCityOrTown
Palo Alto
CY2024 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94303
CY2024 dei City Area Code
CityAreaCode
650
CY2024 dei Local Phone Number
LocalPhoneNumber
719-5286
CY2024 dei Security12b Title
Security12bTitle
Common Stock
CY2024 dei Trading Symbol
TradingSymbol
MEDE
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
true
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6666500 shares
CY2024Q2 dei Entity Public Float
EntityPublicFloat
0 usd
CY2024 dei Auditor Firm
AuditorFirmId
6797
CY2024 dei Auditor Name
AuditorName
Bush & Associates CPA LLC
CY2024 dei Auditor Location
AuditorLocation
Henderson, Nevada
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
402 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1862 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
402 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1862 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
0 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
28183 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22939 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30725 usd
CY2024Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
22939 usd
CY2023Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
58908 usd
CY2024Q1 us-gaap Assets
Assets
23341 usd
CY2023Q1 us-gaap Assets
Assets
60770 usd
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10169 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1001 usd
CY2024Q1 MEDE Loans From Related Parties
LoansFromRelatedParties
63440 usd
CY2023Q1 MEDE Loans From Related Parties
LoansFromRelatedParties
55467 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
73609 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
56468 usd
CY2024Q1 MEDE Note Payable Related Party
NotePayableRelatedParty
12500 usd
CY2023Q1 MEDE Note Payable Related Party
NotePayableRelatedParty
12500 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
25500 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
25500 usd
CY2024Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
38000 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
38000 usd
CY2024Q1 us-gaap Liabilities
Liabilities
111609 usd
CY2023Q1 us-gaap Liabilities
Liabilities
94468 usd
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6666500 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6666500 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6666500 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6666500 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
667 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
667 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26899 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26899 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-115834 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61264 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-88268 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-33698 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23341 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
60770 usd
CY2024 us-gaap Revenues
Revenues
0 usd
CY2023 us-gaap Revenues
Revenues
1838 usd
CY2024 us-gaap Gross Profit
GrossProfit
0 usd
CY2023 us-gaap Gross Profit
GrossProfit
1838 usd
CY2024 us-gaap Professional Fees
ProfessionalFees
17473 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
40228 usd
CY2024 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21974 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22929 usd
CY2024 us-gaap Operating Expenses
OperatingExpenses
39447 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
63157 usd
CY2024 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 usd
CY2023 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1095 usd
CY2024 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-401 usd
CY2024 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
15123 usd
CY2023 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
-0 usd
CY2024 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-15123 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
694 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-54570 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-60625 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-54570 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-60625 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6666500 shares
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6666500 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4940726 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4940726 shares
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-54570 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-88268 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
27166 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-60625 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-33698 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
-54570 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-60625 usd
CY2024 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
28183 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10976 usd
CY2024 us-gaap Depreciation
Depreciation
7788 usd
CY2023 us-gaap Depreciation
Depreciation
7788 usd
CY2024 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
9168 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1001 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9432 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40860 usd
CY2024 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
-0 usd
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
12500 usd
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12500 usd
CY2024 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
27166 usd
CY2024 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
7973 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
15156 usd
CY2024 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
CY2023 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
12500 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7973 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
54822 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1460 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1462 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1862 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
400 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
402 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1862 usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-115834 usd
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2024 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84D_eus-gaap--UseOfEstimates_z7IiXB2zI3L3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates and Assumptions</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Due to the limited level of operations, the Company has not had to make material assumptions or estimates other than the assumption that the Company is a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q1 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
38930 usd
CY2024Q1 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
CY2024 us-gaap Depreciation
Depreciation
7788 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15992 usd
CY2024Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P3Y
CY2024 us-gaap Adjustment For Amortization
AdjustmentForAmortization
13060 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
24057 usd
CY2024 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
15123 usd
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6666500 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6666500 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6666500 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6666500 shares
CY2024 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
24325 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
12865 usd
CY2024 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
24325 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
12865 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
24325 usd
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
12865 usd
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
24325 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
12865 usd
CY2024Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2024Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
115834 usd
CY2024 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-004100-index-headers.html Edgar Link pending
0001683168-24-004100-index.html Edgar Link pending
0001683168-24-004100.txt Edgar Link pending
0001683168-24-004100-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_008.jpg Edgar Link pending
image_014.jpg Edgar Link pending
image_015.jpg Edgar Link pending
mede-20240229.xsd Edgar Link pending
medies_ex2301.htm Edgar Link pending
medies_ex3100.htm Edgar Link pending
medies_ex3200.htm Edgar Link pending
medies_i10k-022924.htm Edgar Link pending
medies_i10k-022924_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mede-20240229_cal.xml Edgar Link unprocessable
mede-20240229_pre.xml Edgar Link unprocessable
mede-20240229_def.xml Edgar Link unprocessable
mede-20240229_lab.xml Edgar Link unprocessable